NovaBridge Biosciences
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $368.9M
Liabilities Breakdown FY2023
Total Liabilities: $126.3M
Asset Breakdown
Total Assets: $368.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $291.5M | 79.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.8M | 0.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $16.6M | 4.5% |
| Other Assets | $59.0M | 16.0% |
Liabilities Breakdown
Total Liabilities: $126.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.8M | 6.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $118.5M | 93.8% |